MD Nutritionals Indolplex

Women: Take 2 Vcaps® once to twice daily or as directed by your healthcare practitioner.
Men: Take 2 Vcaps® twice daily or as directed by your healthcare practitioner.

Indolplex® 65mg
Equiv. microencapsulated DIM 20mg
Excipient Ingredients:
Cellulose microcrystalline, calcium hydrogen phosphate, silicon dioxide and magnesium stearate (vegetable source).
Contains no gluten, dairy, yeast, wheat, animal products, artificial flavours, colours or preservatives.

Do not use Indolplex® if you are pregnant, may become pregnant or are lactating.
Harmless changes in urine colour may occur with Indolplex®. Increased water consumption can reduce this side effect.
• Symptoms of nausea and/or headaches may occur with Indolplex®. Indolplex® assists activity of hepatic cytochrome P450 enzymes (CYP1A1/1A2) pathways. Nutrients required to support phase 2 liver detoxification pathways can assist in reducing these symptoms.
• Indolplex® does not contain goitrogenic compounds which could affect thyroid function.
• A short term increase in symptoms with Indolplex® may be due to increased metabolism of available oestrogen.
• Indolplex® can be used in used in conjunction with phytoestrogenic herbs.
• Indolplex® may assist hormone health when taken with Hormone Replacement Therapy (HRT).
• Indolplex® may assist hormone health when taken with the oral contraceptive pill (OCP). Indolplex® has no inducing action on CYP3A4, the enzyme that metabolises the OCP. Therefore, Indolplex® does not affect efficacy of the OCP.
• Indolplex® may assist effective metabolism of increased available oestrogen when taken with bioidentical hormone replacement therapy (BHRT).
• Safety studies support concomitant use of Indolplex® with Tamoxifen.19
• Combined use of Indolplex® and Zoladex is supported.
• Indolplex® should be used with caution in patients taking anticoagulation medications.